| Financial Year |
March 31 2023 |
| Monetary Funds |
46,662,999.96 |
| Held-for-trading Financial Assets |
394,508.76 |
| Notes Receivable |
63,120,842.83 |
| Accounts Receivable |
138,720,038.58 |
| Advances to Suppliers |
1,568,490.70 |
| Other Receivables |
1,968,935.17 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
176,590,033.62 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
23,178,734.60 |
| Total Current Assets |
480,132,319.72 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
304,363,574.14 |
| Investment Properties |
9,988,327.22 |
| Fixed Assetes |
230,900,245.85 |
| Under-construction Projects |
6,728,958.24 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
25,628,782.15 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
9,825,681.46 |
| Other Non-Current Assets |
23,946,559.65 |
| Sub-Total of Non-Current Assets |
611,382,128.71 |
| Total Assets |
1,091,514,448.43 |
| Short-Term Loans |
215,878,459.74 |
| Trading Financial liabilities |
391,809.44 |
| Notes Payable |
-- |
| Accounts Payable |
32,732,482.15 |
| Accounts Received In Advance |
3,150,000.00 |
| Employee Compensation Payable |
15,192,136.38 |
| Taxes Payable |
2,390,305.71 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,502,335.84 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
94,945,650.55 |
| Sub-Total of Current Liabilities |
372,164,490.03 |
| Long-term Loans |
50,004,444.44 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
175,142.74 |
| Deferred Income Tax Liabilities |
1,672,453.80 |
| Other Non-Current Liabilities |
43,376,420.76 |
| Sub-Total of Non-Current Liabilities |
106,605,657.69 |
| Total Liabilities |
478,770,147.72 |
| Paid-In Capital(Or Share Stock) |
180,000,000.00 |
| Capital Surplus |
130,157,577.42 |
| Surplus Reserve |
14,283,251.26 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
288,303,472.03 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
612,744,300.71 |
| Owner's Equity（Stockholder's Equity） |
612,744,300.71 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,091,514,448.43 |
